Conclusions
The use of Preventogen in patients undergoing surgery resulted in a significant reduction of SSI rates with no observed 30-day SSI in a patient cohort expected to have a 4% SSI rate. Preventogen liquid Polymer can be safely used as elastomeric see-through dressing in clean and clean contaminated surgical cases to significantly reduce SSI rates. Use of this polymer can decrease the incidence of wound infection and the need for systemic antibiotics who’s use can contribute to antibiotic resistance and other complications related to antibiotic therapy. Healing these complex wounds with fewer systemic antibiotics in a shorter span of time can save lives and limbs.
